The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
288 - If we are to conduct comparative analysis (our product vs. marketed products from the same category) to support a claim to be presented to HCP, what are the standards that the study and resutls should meet for PAAB to consider it acceptable?
-
I need a bit more info to provide an answer. Please clarify the following two parameters: the nature of the comparisoni.e. therapeutic comparison relating to efficacy/safety, pharmacoeconomic comparison, retention, format availability, other non-clinical features (e.g. receptor affinity/potency, MOA, preference, cosmetic/sensory attributes), etcÂ…the nature of the sourcei.e. a survey, a published clinical trial, product monographs, third party data, etcÂ…
